메뉴 건너뛰기




Volumn 45, Issue 4, 2006, Pages 361-363

Narcolepsy with cataplexy in early childhood

Author keywords

[No Author keywords available]

Indexed keywords

CLONIDINE; DEXAMPHETAMINE; METHYLPHENIDATE; NORTRIPTYLINE; PEMOLINE; THIORIDAZINE; VENLAFAXINE;

EID: 33646861612     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280604500409     Document Type: Article
Times cited : (18)

References (21)
  • 1
    • 33646863432 scopus 로고    scopus 로고
    • Age of onset and time to diagnosis of narcolepsy
    • Thorpy MJ, Cronin S, Temple H. Age of onset and time to diagnosis of narcolepsy. Neurology. 1999;52(suppl 2):A110.
    • (1999) Neurology , vol.52 , Issue.2 SUPPL.
    • Thorpy, M.J.1    Cronin, S.2    Temple, H.3
  • 2
    • 0035119687 scopus 로고    scopus 로고
    • Current concepts in the etiology, diagnosis and treatment of narcolepsy
    • Thorpy M. Current concepts in the etiology, diagnosis and treatment of narcolepsy. Sleep Med. 2001;2:5-17.
    • (2001) Sleep Med , vol.2 , pp. 5-17
    • Thorpy, M.1
  • 3
    • 0003104275 scopus 로고
    • A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with narcolepsy or hypersomnia probands
    • Guilleminault C, Lugaresi E, eds. New York, NY: Raven Press
    • Honda Y, Asaka A, Tanimura M, et al. A genetic study of narcolepsy and excessive daytime sleepiness in 308 families with narcolepsy or hypersomnia probands. In: Guilleminault C, Lugaresi E, eds. Sleep Wake Disorders Natural History, Epidemiology and Long Term Evolution. New York, NY: Raven Press; 1983:187-199.
    • (1983) Sleep Wake Disorders Natural History, Epidemiology and Long Term Evolution , pp. 187-199
    • Honda, Y.1    Asaka, A.2    Tanimura, M.3
  • 4
    • 0034967934 scopus 로고    scopus 로고
    • Narcolepsy: Clinical features, new pathophysiologic insights, and future perspectives
    • Overeem S, Mignot E, Gert van Dijk J, et al. Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives. J Clin Neurophysiol. 2001;18:78-105.
    • (2001) J Clin Neurophysiol , vol.18 , pp. 78-105
    • Overeem, S.1    Mignot, E.2    Gert Van Dijk, J.3
  • 5
    • 0036467285 scopus 로고    scopus 로고
    • Clinical aspects of narcolepsy-cataplexy across ethnic groups
    • Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep. 2002;25:27-35.
    • (2002) Sleep , vol.25 , pp. 27-35
    • Okun, M.L.1    Lin, L.2    Pelin, Z.3
  • 6
    • 0028222567 scopus 로고
    • The prevalence of narcolepsy: An epidemiological study of the Finnish Twin Cohort
    • Hublin C, Kaprio J, Partinen M, et al. The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol. 1994;35:709-716.
    • (1994) Ann Neurol , vol.35 , pp. 709-716
    • Hublin, C.1    Kaprio, J.2    Partinen, M.3
  • 7
    • 0031912090 scopus 로고    scopus 로고
    • Genetic and familial aspects of narcolepsy
    • Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 1998;50(suppl 1):S16-22.
    • (1998) Neurology , vol.50 , Issue.1 SUPPL.
    • Mignot, E.1
  • 8
    • 0023277036 scopus 로고
    • Guidelines for the multiple sleep latency test (MSLT): A standard measure of sleepiness
    • Carskadon MA, Dement WC, Mitler MM, et al. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep. 1986;9:519-524.
    • (1986) Sleep , vol.9 , pp. 519-524
    • Carskadon, M.A.1    Dement, W.C.2    Mitler, M.M.3
  • 9
    • 0033971611 scopus 로고    scopus 로고
    • Hypocretin (orexin) deficiency in human narcolepsy
    • Nishino S, Ripley B, Overeem S, et al. Hypocretin (orexin) deficiency in human narcolepsy. Lancet. 2000;355:39-40.
    • (2000) Lancet , vol.355 , pp. 39-40
    • Nishino, S.1    Ripley, B.2    Overeem, S.3
  • 10
    • 0034846670 scopus 로고    scopus 로고
    • Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy
    • Nishino S, Ripley B, Overeem S, et al. Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy. Ann Neurol. 2001;50:381-388.
    • (2001) Ann Neurol , vol.50 , pp. 381-388
    • Nishino, S.1    Ripley, B.2    Overeem, S.3
  • 11
    • 0035956531 scopus 로고    scopus 로고
    • CSF hypocretin/orexin levels in narcolepsy and other neurological conditions
    • Ripley B, Overeem S, Fujiki N, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions. Neurology. 2001;57:2253-2258.
    • (2001) Neurology , vol.57 , pp. 2253-2258
    • Ripley, B.1    Overeem, S.2    Fujiki, N.3
  • 12
    • 0036119164 scopus 로고    scopus 로고
    • CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia
    • Kanbayashi T, Inoue Y, Chiba S, et al. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia. J Sleep Res. 2002;11:91-93.
    • (2002) J Sleep Res , vol.11 , pp. 91-93
    • Kanbayashi, T.1    Inoue, Y.2    Chiba, S.3
  • 13
    • 0033826856 scopus 로고    scopus 로고
    • A mutation in early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
    • Peyron C, Faraco J, Rogers W, et al. A mutation in early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6:991-997.
    • (2000) Nat Med , vol.6 , pp. 991-997
    • Peyron, C.1    Faraco, J.2    Rogers, W.3
  • 14
    • 0033710848 scopus 로고    scopus 로고
    • Reduced number of hypocretin neurons in human narcolepsy
    • Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27:467-474.
    • (2000) Neuron , vol.27 , pp. 467-474
    • Thannickal, T.C.1    Moore, R.Y.2    Nienhuis, R.3
  • 15
    • 0034784993 scopus 로고    scopus 로고
    • Low cerebrospinal fluid hypocretin levels found in familial narcolepsy
    • Hartwig G, Harsh J, Ripley B, et al. Low cerebrospinal fluid hypocretin levels found in familial narcolepsy. Sleep Med. 2001;2:451-453.
    • (2001) Sleep Med , vol.2 , pp. 451-453
    • Hartwig, G.1    Harsh, J.2    Ripley, B.3
  • 16
    • 0028596909 scopus 로고
    • DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans
    • Mignot E, Lin X, Arrigoni J, et al. DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. Sleep. 1994;17:S60-66.
    • (1994) Sleep , vol.17
    • Mignot, E.1    Lin, X.2    Arrigoni, J.3
  • 17
    • 0031283162 scopus 로고    scopus 로고
    • DQB1*0602 is associated with cataplexy in 509 narcoleptic patients
    • Mignot E, Hayduk R, Black J, et al. DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep. 1997;20:1012-1020.
    • (1997) Sleep , vol.20 , pp. 1012-1020
    • Mignot, E.1    Hayduk, R.2    Black, J.3
  • 18
    • 0035091595 scopus 로고    scopus 로고
    • Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups
    • Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Ann J Hum Genet. 2001;68:686-699.
    • (2001) Ann J Hum Genet , vol.68 , pp. 686-699
    • Mignot, E.1    Lin, L.2    Rogers, W.3
  • 19
    • 10344256688 scopus 로고    scopus 로고
    • A functional autoantibody in narcolepsy
    • Smith AJ, Jackson MW, Neufing P, et al. A functional autoantibody in narcolepsy. Lancet. 2004;364:2122-2124.
    • (2004) Lancet , vol.364 , pp. 2122-2124
    • Smith, A.J.1    Jackson, M.W.2    Neufing, P.3
  • 20
    • 0036791834 scopus 로고    scopus 로고
    • The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias
    • Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59:1553-1562.
    • (2002) Arch Neurol , vol.59 , pp. 1553-1562
    • Mignot, E.1    Lammers, G.J.2    Ripley, B.3
  • 21
    • 19944425802 scopus 로고    scopus 로고
    • CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders
    • Arii J, Kanbayashi T, Tanabe Y, et al. CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders. Neurology. 2004;63:2440-2442.
    • (2004) Neurology , vol.63 , pp. 2440-2442
    • Arii, J.1    Kanbayashi, T.2    Tanabe, Y.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.